U.S. Markets closed

Kiniksa Pharmaceuticals, Ltd. (KNSA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
15.33+0.40 (+2.68%)
At close: 4:00PM EDT
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
No. of Analysts4444
Avg. Estimate-0.79-0.72-2.98-2.36
Low Estimate-1.16-0.86-3.71-3.06
High Estimate-0.63-0.61-2.51-1.65
Year Ago EPS-0.65-0.66-2.61-2.98
Revenue EstimateCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
No. of Analysts4455
Avg. Estimate3.97M6.83M20.45M100.28M
Low Estimate2.56M3.6M10.99M63.26M
High Estimate7M10M28.48M134M
Year Ago SalesN/AN/AN/A20.45M
Sales Growth (year/est)N/AN/AN/A390.40%
Earnings History6/29/20209/29/202012/30/20203/30/2021
EPS Est.-0.63-0.6-0.62-0.72
EPS Actual-0.65-0.66-0.79-0.72
Difference-0.02-0.06-0.170
Surprise %-3.20%-10.00%-27.40%0.00%
EPS TrendCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
Current Estimate-0.79-0.72-2.98-2.36
7 Days Ago-0.79-0.72-2.98-2.36
30 Days Ago-0.79-0.72-2.98-2.36
60 Days Ago-0.76-0.68-2.82-2.33
90 Days Ago-0.67-0.8-2.88-2.53
EPS RevisionsCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesKNSAIndustrySector(s)S&P 500
Current Qtr.-21.50%N/AN/AN/A
Next Qtr.-9.10%N/AN/AN/A
Current Year-14.20%N/AN/AN/A
Next Year20.80%N/AN/AN/A
Next 5 Years (per annum)-112.30%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A